Sri Sai Subramanyam Challa (2021) “EVALUATING THE EFFECTIVENESS OF RISK-BASED APPROACHES IN STREAMLINING THE REGULATORY APPROVAL PROCESS FOR NOVEL THERAPIES”, Journal of Population Therapeutics and Clinical Pharmacology, 28(2), pp. 436–448. doi:10.53555/jptcp.v28i2.7421.